Recent years have witnessed remarkable developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://jimbaaz044448.iyublog.com/37848778/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide